Zhejiang Hangyu API Co., Ltd is a market-oriented and innovation-driven biopharmaceutical company. The company is focusing on the R&D, manufacturing and sales of pharmaceutical products both for peptide and small molecule. Through technical innovation, the company is committed to solving technical bottlenecks in research and production, optimizing manufacturing processes, building a whole product chain covering advanced intermediates, bug tolerance and bug products, so as to provide high quality, green and cost efficient products and services for the global pharmaceutical markets.
Company pays great attention to research and innovation Though more than 11 years, the company has successfully developed five technology platforms. They are: large scale solid-solution phase hybrid production technology, chiral-drug design and selection technology...
|
